Observational studyScientific reports2025
Association of serum osmolality levels with all-cause mortality risk in patients with DKA.
Observational study in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The purpose of this study was to investigate the relationship. between serum osmolality levels and 28-day mortality in patients with DKA. Data for this observational cohort study were obtained from the MIMIC-IV3.0 database. The participants were divided into five groups based on the serum osmolality quintiles. The primary outcome was 28-day mortality. We employed Cox proportional hazards regression analysis and threshold effect analysis to assess. the relationship between serum osmolality levels and 28-day mortality in patients with DKA. The study included 1026 patients; the mean age was 52 years, 55.0% were male. Our findings indicate that serum osmolality is associated with an increased risk of 28-day mortality, exhibiting a U-shaped relationship. Altered serum osmolality levels, whether lower or higher, are linked to a heightened risk of mortality. When osmolality < 306.8 mOsm/kg, the 28-day mortality risk decreased by 6.2% (HR 0.938, 95% CI 0.912-0.964) for every 1 mOsm/kg increase. At osmolality ≥ 306.8 mOsm/kg, there was a 3.7% (HR 1.037, 95% CI 1.030-1.045) increase in the 28-day mortality risk for every 1 mOsm/kg increase in osmolality. The risk of mortality was lower at osmolality of 284-299 mOsm/kg. A U-shaped correlation between initial serum osmolality and 28-. days all-cause mortality in patients with DKA was identified. These results underscore. serum osmolality's critical role in early mortality among patients with DKA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.